Chemical Structure (Tapentadol 01)
Tapentadol Tablet, Film Coated, Extended Release
Product Images NDC 0054-0939
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Tapentadol (NDC 0054-0939). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Chemical Structure (Tapentadol 02)
This description indicates the percentage improvement in pain from baseline at week 15 of the treatment period, with different ranges beginning from 0 up to 100. The data is likely part of a study or analysis assessing the effectiveness of a treatment in reducing pain levels over time.*
Chemical Structure (Tapentadol 03)
Chemical Structure (Tapentadol 04)
This text contains a statistical overview of the percent of patents improved in a study, specifically focusing on the percent improvement in pain from baseline at week 12 of the double-blind period. The data appears to be categorized based on different percentage ranges, indicating the level of improvement.*
Principal Display Panel (50 mg Tablet Bottle Label)
Description: The text includes information about Tapentadol Extended-Release Tablets. It states that each tablet contains 50mg of Tapentadol and provides caution regarding the transfer of the drug as per federal law. It advises to swallow the tablets whole without chewing, crushing, or dissolving them. The National Drug Code (NDC) for the tablets is 0054-0936-21. The text also includes alphanumeric characters and what seems to be a code or reference at the end.*
Principal Display Panel (100 mg Tablet Bottle Label)
Principal Display Panel (150 mg Tablet Bottle Label)
Principal Display Panel (200 mg Tablet Bottle Label)
Principal Display Panel (250 mg Tablet Bottle Label)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
